本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Mineralys Therapeutics, Inc.

27.54
-1.3700-4.74%
盤後27.540.00000.00%19:30 EDT
成交量:141.55萬
成交額:3,920.11萬
市值:24.28億
市盈率:-6.29
高:29.09
開:28.98
低:27.33
收:28.91
52周最高:47.65
52周最低:22.30
股本:8,815.85萬
流通股本:6,602.58萬
量比:0.94
換手率:2.14%
股息:- -
股息率:- -
每股收益(TTM):-4.3763
每股收益(LYR):-2.2900
淨資產收益率:-80.88%
總資產收益率:-46.18%
市淨率:4.41
市盈率(LYR):-12.03

資料載入中...

2025/01/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/08

重要事件披露

Form 8-K - Current report
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/25

重要事件披露

Form 8-K - Current report
2024/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities